International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions.

Landau-Kleffner syndrome Lennox-Gastaut syndrome Panayiotopoulos syndrome benign occipital epilepsy childhood epilepsy with centrotemporal spikes continuous spike-and-wave in sleep eyelid myoclonia febrile infection-related epilepsy syndrome hemiconvulsion-hemiplegia-epilepsy syndrome myoclonic absences myoclonic atonic

Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
06 2022
Historique:
revised: 16 03 2022
received: 24 04 2021
accepted: 17 03 2022
pubmed: 4 5 2022
medline: 7 6 2022
entrez: 3 5 2022
Statut: ppublish

Résumé

The 2017 International League Against Epilepsy classification has defined a three-tier system with epilepsy syndrome identification at the third level. Although a syndrome cannot be determined in all children with epilepsy, identification of a specific syndrome provides guidance on management and prognosis. In this paper, we describe the childhood onset epilepsy syndromes, most of which have both mandatory seizure type(s) and interictal electroencephalographic (EEG) features. Based on the 2017 Classification of Seizures and Epilepsies, some syndrome names have been updated using terms directly describing the seizure semiology. Epilepsy syndromes beginning in childhood have been divided into three categories: (1) self-limited focal epilepsies, comprising four syndromes: self-limited epilepsy with centrotemporal spikes, self-limited epilepsy with autonomic seizures, childhood occipital visual epilepsy, and photosensitive occipital lobe epilepsy; (2) generalized epilepsies, comprising three syndromes: childhood absence epilepsy, epilepsy with myoclonic absence, and epilepsy with eyelid myoclonia; and (3) developmental and/or epileptic encephalopathies, comprising five syndromes: epilepsy with myoclonic-atonic seizures, Lennox-Gastaut syndrome, developmental and/or epileptic encephalopathy with spike-and-wave activation in sleep, hemiconvulsion-hemiplegia-epilepsy syndrome, and febrile infection-related epilepsy syndrome. We define each, highlighting the mandatory seizure(s), EEG features, phenotypic variations, and findings from key investigations.

Identifiants

pubmed: 35503717
doi: 10.1111/epi.17241
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1398-1442

Subventions

Organisme : NINDS NIH HHS
ID : U54 NS100064
Pays : United States

Informations de copyright

© 2022 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.

Références

Riney K, Bogacz A, Somerville E, Hirsch E, Nabbout R, Scheffer I. Classification and definition of epilepsy syndromes with onset in adolescents, adults, and at a variable age: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia. In press.
Hirsch E, French J, Scheffer I, Zuberi S, Trinka E, Specchio N. Definition of the idiopathic generalized epilepsy syndromes: position paper by the ILAE Task Force on Nosology and Definitions. Epilepsia. In press.
Caraballo RH, Sologuestua A, Grañana N, Adi JN, Cersósimo RO, Mazza E, et al. Idiopathic occipital and absence epilepsies appearing in the same children. Pediatr Neurol. 2004;30(1):24-8.
Verrotti A, D’Alonzo R, Rinaldi VE, Casciato S, D’Aniello A, Di Gennaro G. Childhood absence epilepsy and benign epilepsy with centro-temporal spikes: a narrative review analysis. World J Pediatr. 2017;13(2):106-11.
Wirrell EC, Grossardt BR, Wong-Kisiel LCL, Nickels KC. Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: a population-based study. Epilepsy Res. 2011;95(1-2):110-8.
Camfield P, Camfield C. Incidence, prevalence and aetiology of seizures and epilepsy in children. Epileptic Disord. 2015;17(2):117-23.
Wirrell E, Nabbout R, Scheffer I, Alsaadi T, Bogacz A. Methodology for classification and definition of epilepsy syndromes with list of syndromes: report of the ILAE Task Force on Nosology and Definitions. Epilepsia. In press.
Bureau M, Genton P, Dravet C, Antonio D-E, Guerrini R, Alberto TC. In: Bureau M, Genton P, Dravet C, Antonio D-E, Guerrini R, Alberto TC, et al., editors. Epileptic syndromes of infancy, childhood and adolescence. 6th ed. Montrouge, France: John Libbey Eurotext; 2019.
Wirrell EC, Grossardt BR, So EL, Nickels KC. A population-based study of long-term outcomes of cryptogenic focal epilepsy in childhood: cryptogenic epilepsy is probably not symptomatic epilepsy. Epilepsia. 2011;52(4):738-45.
Berg AT, Rychlik K, Levy SR, Testa FM. Complete remission of childhood-onset epilepsy: stability and prediction over two decades. Brain. 2014;137(12):3213-22.
Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51(4):676-85.
Lesca G, Møller RS, Rudolf G, Hirsch E, Hjalgrim H, Szepetowski P. Update on the genetics of the epilepsy-aphasia spectrum and role of GRIN2A mutations. Epileptic Disord. 2019;21(S1):41-7.
Lemke JR, Lal D, Reinthaler EM, Steiner I, Nothnagel M, Alber M, et al. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet. 2013;45(9):1067-72.
Lesca G, Rudolf G, Bruneau N, Lozovaya N, Labalme A, Boutry-Kryza N, et al. GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat Genet. 2013;45(9):1061-6.
Carvill GL, Regan BM, Yendle SC, O'Roak BJ, Lozovaya N, Bruneau N, et al. GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nat Genet. 2013;45(9):1073-6.
Demirbilek V, Bureau M, Cokar O, Panayiotopoulos CP. Self-limited focal epilepsies in childhood. In: Bureau M, Genton P, Dravet C, Delgado-Escueta A, Guerrini R, Tassinari C, et al., editors. Epileptic syndromes in infancy childhood and adolescence. 6th ed. Montrouge, France: John Libbey Eurotext; 2019. p. 219-60.
Panayiotopoulos CP, Michael M, Sanders S, Valeta T, Koutroumanidis M. Benign childhood focal epilepsies: assessment of established and newly recognized syndromes. Brain. 2008;131(9):2264-86.
Taylor I, Berkovic SF, Kivity S, Scheffer IE. Benign occipital epilepsies of childhood: clinical features and genetics. Brain. 2008;131(9):2287-94.
Loiseau P, Beaussart M. The seizures of benign childhood epilepsy with Rolandic paroxysmal discharges. Epilepsia. 1973;14(4):381-9.
Dalla Bernardina B, Sgrò V, Caraballo R, Fontana E, Colamaria V, Zullini E, et al. Sleep and benign partial epilepsies of childhood: EEG and evoked potentials study. Epilepsy Res Suppl. 1991;2:83-96.
Pal DK, Ferrie C, Addis L, Akiyama T, Capovilla G, Caraballo R, et al. Idiopathic focal epilepsies: the “lost tribe”. Epileptic Disord. 2016;18(3):252-88.
Vears DF, Tsai M-H, Sadleir LG, Grinton BE, Lillywhite LM, Carney PW, et al. Clinical genetic studies in benign childhood epilepsy with centrotemporal spikes. Epilepsia. 2012;53(2):319-24.
Camfield CS, Camfield PR, Gordon K, Wirrell E, Dooley JM. Incidence of epilepsy in childhood and adolescence: a population-based study in Nova Scotia from 1977 to 1985. Epilepsia. 1996;37(1):19-23.
Weir E, Gibbs J, Appleton R. Panayiotopoulos syndrome and benign partial epilepsy with centro-temporal spikes: a comparative incidence study. Seizure. 2018;57:66-9.
Astradsson A, Olafsson E, Ludvigsson P, Bjorgvinsson H, Hauser WA. Rolandic Epilepsy: an incidence study in Iceland. Epilepsia. 1998;39(8):884-6.
Berg AT, Shinnar S, Levy SR, Testa FM. Newly diagnosed epilepsy in children: presentation at diagnosis. Epilepsia. 1999;40(4):445-52.
Beaussart M. Benign epilepsy of children with Rolandic (centro-temporal) paroxysmal foci. A clinical entity. Study of 221 cases. Epilepsia. 1972;13(6):795-811.
Larsson K, Eeg-Olofsson O. A population based study of epilepsy in children from a Swedish county. Eur J Paediatr Neurol. 2006;10(3):107-13.
Caraballo R, Cersósimo R, Fejerman N. Panayiotopoulos syndrome: a prospective study of 192 patients. Epilepsia. 2007;48(6):1054-61.
Overvliet GM, Aldenkamp AP, Klinkenberg S, Vles JSH, Hendriksen J. Impaired language performance as a precursor or consequence of Rolandic epilepsy? J Neurol Sci. 2011;304(1-2):71-4.
Bouma PAD, Bovenkerk AC, Westendorp RGJ, Brouwer OF. The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis. Neurology. 1997;48(2):430-7.
Goldberg-Stern H, Gonen OM, Sadeh M, Kivity S, Shuper A, Inbar D. Neuropsychological aspects of benign childhood epilepsy with centrotemporal spikes. Seizure. 2010;19(1):12-6.
Filippini M, Ardu E, Stefanelli S, Boni A, Gobbi G, Benso F. Neuropsychological profile in new-onset benign epilepsy with centrotemporal spikes (BECTS): focusing on executive functions. Epilepsy Behav. 2016;54:71-9.
Deonna T. Rolandic epilepsy: neuropsychology of the active epilepsy phase. Epileptic Disord. 2000;2(Suppl 1):S59-61.
Camfield PR, Camfield CS. What happens to children with epilepsy when they become adults? Some facts and opinions. Pediatr Neurol. 2014;51(1):17-23.
Camfield P, Camfield C. Unprovoked status epilepticus: the prognosis for otherwise normal children with focal epilepsy. Pediatrics. 2012;130(3):e501-6.
Wirrell EC, Camfield PR, Gordon KE, Dooley JM, Camfield CS. Benign Rolandic epilepsy: atypical features are very common. J Child Neurol. 1995;10(6):455-8.
Hirsch LJ, Fong MWK, Leitinger M, LaRoche SM, Beniczky S, Abend NS, et al. American clinical neurophysiology society’s standardized critical care EEG terminology: 2021 version. J Clin Neurophysiol. 2021;38(1):1-29.
Panayiotopoulos CP. Elementary visual hallucinations, blindness, and headache in idiopathic occipital epilepsy: differentiation from migraine. J Neurol Neurosurg Psychiatry. 1999;66(4):536-40.
Deonna TR, Roulet Perez E, de Tiege X, Van Bogaert P. The epilepsy aphasia spectrum: from Landau-Kleffner syndrome to Rolandic epilepsy. Chichester, UK: Wiley; 2017.
De MP, Tassinari CA. Extreme somatosensory evoked potential (ESEP): an EEG sign forecasting the possible occurrence of seizures in children. Epilepsia. 1981;22(5):569-75.
Scheffer IE, Jones L, Pozzebon M, Howell RA, Saling MM, Berkovic SF. Autosomal dominant rolandic epilepsy and speech dyspraxia: a new syndrome with anticipation. Ann Neurol. 1995;38(4):633-42.
Capovilla G, Beccaria F, Bianchi A, Canevini MP, Giordano L, Gobbi G, et al. Ictal EEG patterns in epilepsy with centro-temporal spikes. Brain Dev. 2011;33(4):301-9.
Alving J, Fabricius M, Rosenzweig I, Beniczky S. Ictal source imaging and electroclinical correlation in self-limited epilepsy with centrotemporal spikes. Seizure. 2017;52:7-10.
Saint-Martin AD, Carcangiu R, Arzimanoglou A, Massa R, Thomas P, Motte J, et al. Semiology of typical and atypical Rolandic epilepsy: a video-EEG analysis. Epileptic Disord. 2001;3(4):173-82.
Gelisse P, Corda D, Raybaud C, Dravet C, Bureau M, Genton P. Abnormal neuroimaging in patients with benign epilepsy with centrotemporal spikes. Epilepsia. 2003;44(3):372-8.
Jabbari K, Bobbili DR, Lal D, Reinthaler EM, Schubert J, Wolking S, et al. Rare gene deletions in genetic generalized and Rolandic epilepsies. PLoS One. 2018;13(8):e0202022.
Berry-Kravis E. Epilepsy in fragile X syndrome. Dev Med Child Neurol. 2002;44(11):724-8.
Musumeci SA, Hagerman RJ, Ferri R, Bosco P, Bernardina BD, Tassinari CA, et al. Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia. 1999;40(8):1092-9.
Ferrie CD, Caraballo R, Covanis A, Demirbilek V, Dervent A, Fejerman N, et al. Autonomic status epilepticus in Panayiotopoulos syndrome and other childhood and adult epilepsies: a consensus view. Epilepsia. 2007;48(6):1165-72.
Specchio N, Trivisano M, Di Ciommo V, Cappelletti S, Masciarelli G, Volkov J, et al. Panayiotopoulos syndrome: a clinical, EEG, and neuropsychological study of 93 consecutive patients. Epilepsia. 2010;51(10):2098-107.
Panayiotopoulos CP. Vomiting as an ictal manifestation of epileptic seizures and syndromes. J Neurol Neurosurg Psychiatry. 1988;51(11):1448-51.
Okanishi T, Maegaki Y, Ohno K, Togari H. Underlying neurologic disorders and recurrence rates of status epilepticus in childhood. Brain Dev. 2008;30(10):624-8.
Panayiotopoulos CP. Panayiotopoulos syndrome: a common and benign childhood epileptic syndrome. Eastleigh, England: John Libbey & Company; 2002.
Lada C, Skiadas K, Theodorou V, Loli N, Covanis A. A study of 43 patients with Panayiotopoulos syndrome, a common and benign childhood seizure susceptibility. Epilepsia. 2003;44(1):81-8.
Durá-Travé T, Yoldi-Petri ME, Gallinas-Victoriano F. Incidence of epilepsies and epileptic syndromes among children in Navarre, Spain: 2002 through 2005. J Child Neurol. 2008;23(8):878-82.
Ferrie C, Caraballo R, Covanis A, Demirbilek V, Dervent A, Kivity S, et al. Panayiotopoulos syndrome: a consensus view. Dev Med Child Neurol. 2006;48(3):236-40.
Specchio N, Trivisano M, Claps D, Battaglia D, Fusco L, Vigevano F. Documentation of autonomic seizures and autonomic status epilepticus with ictal EEG in Panayiotopoulos syndrome. Epilepsy Behav. 2010;19(3):383-93.
Grosso S, Orrico A, Galli L, Di Bartolo R, Sorrentino V, Balestri P. SCN1A mutation associated with atypical Panayiotopoulos syndrome. Neurology. 2007;69(6):609-11.
Livingston JH, Cross JH, Mclellan A, Birch R, Zuberi SM. A novel inherited mutation in the voltage sensor region of SCN1A is associated with Panayiotopoulos syndrome in siblings and generalized epilepsy with febrile seizures plus. J Child Neurol. 2009;24(4):503-8.
Martín del Valle F, Díaz Negrillo A, Ares Mateos G, Sanz Santaeufemia FJ, Del Rosal Rabes T, González-Valcárcel Sánchez-Puelles FJ. Panayiotopoulos syndrome: probable genetic origin, but not in SCN1A. Eur J Paediatr Neurol. 2011;15(2):155-7.
Gastaut H. A new type of epilepsy: benign partial epilepsy of childhood with occipital spike-waves. Clin Electroencephalogr. 1982;13(1):13-22.
Gastaut H, Zifkin BG. Benign epilepsy of childhood with occipital spike and wave complexes. In: Andermann F, Lugaresi E, editors. Migraine and epilepsy. Boston, MA: Butterworths; 1987. p. 47-81.
Verrotti A, Laino D, Rinaldi VE, Suppiej A, Giordano L, Toldo I, et al. Clinical dissection of childhood occipital epilepsy of Gastaut and prognostic implication. Eur J Neurol. 2016;23(2):241-6.
Gastaut H, Roger J, Bureau M. Benign epilepsy of childhood with occipital paroxysms. In: Roger J, Bureau M, Dravet C, Dreifuss F, Perret A, Wolf P, editors. Epileptic syndromes in infancy, childhood and adolescence. 2nd ed. London, UK: John Libbey & Company; 1992. p. 201-17.
Caraballo RH, Cersósimo RO, Fejerman N. Childhood occipital epilepsy of Gastaut: a study of 33 patients. Epilepsia. 2008;49(2):288-97.
Caraballo R, Koutroumanidis M, Panayiotopoulos CP, Fejerman N. Idiopathic childhood occipital epilepsy of Gastaut: a review and differentiation from migraine and other epilepsies. J Child Neurol. 2009;24(12):1536-42.
Thomas P, Arzimanoglou A, Aicardi J. Benign idiopathic occipital epilepsy: report of a case of the late (Gastaut) type [corrected]. Epileptic Disord. 2003;5(1):57-9.
Ferrari-Marinho T, Macedo EF, Costa Neves RS, Costa LV, Tudesco ISS, Carvalho KC, et al. Gastaut type idiopathic childhood occipital epilepsy. Epileptic Disord. 2013;15(1):80-3.
Caraballo RH, Cersósimo RO, Fejerman N. Late-onset, “Gastaut type”, childhood occipital epilepsy: an unusual evolution. Epileptic Disord. 2005;7(4):341-6.
Wakamoto H, Nagao H, Fukuda M, Watanabe S, Motoki T, Ohmori H, et al. Idiopathic childhood occipital epilepsy of Gastaut: report of 12 patients. Pediatr Neurol. 2011;44(3):183-6.
Tsai M-L, Lo H-Y, Chaou W-T. Clinical and electroencephalographic findings in early and late onset benign childhood epilepsy with occipital paroxysms. Brain Dev. 2001;23(6):401-5.
Adcock JE, Panayiotopoulos CP. Occipital lobe seizures and epilepsies. J Clin Neurophysiol. 2012;29(5):397-407.
Guerrini R, Dravet C, Genton P, Bureau M, Bonanni P, Ferrari AR, et al. Idiopathic photosensitive occipital lobe epilepsy. Epilepsia. 1995;36(9):883-91.
Koutroumanidis M, Tsirka V, Panayiotopoulos C. Adult-onset photosensitivity: clinical significance and epilepsy syndromes including idiopathic (possibly genetic) photosensitive occipital epilepsy. Epileptic Disord. 2015;17(3):275-86.
Parmeggiani L, Guerrini R. Idiopathic photosensitive occipital lobe epilepsy. In: Panayiotopoulos CP, editor. Atlas of epilepsies. London, UK: Springer; 2010. p. 1077-80.
Ricci S, Vigevano F, Manfredi M, Kasteleijn-Nolst Trenite DGA. Epilepsy provoked by television and video games: safety of 100-Hz screens. Neurology. 1998;50(3):790-3.
Walker MC, Smith SJM, Sisodiya SM, Shorvon SD. Case of simple partial status epilepticus in occipital lobe epilepsy misdiagnosed as migraine: clinical, electrophysiological, and magnetic resonance imaging characteristics. Epilepsia. 1995;36(12):1233-6.
Taylor I. Juvenile myoclonic epilepsy and idiopathic photosensitive occipital lobe epilepsy: is there overlap? Brain. 2004;127(8):1878-86.
Taylor I, Berkovic SF, Scheffer IE. Genetics of epilepsy syndromes in families with photosensitivity. Neurology. 2013;80(14):1322-9.
Gómez-Porro P, Serrano AA, Toledano R, García-Morales I, Gil-Nagel A. Genetic (idiopathic) generalized epilepsy with occipital semiology. Epileptic Disord. 2018;20(5):434-9.
Brinciotti M, Trasatti G, Pelliccia A, Matricardi M. Pattern-sensitive epilepsy: genetic aspects in two families. Epilepsia. 1992;33(1):88-92.
Destina Yalçin A, Kaymaz A, Forta H. Reflex occipital lobe epilepsy. Seizure. 2000;9(6):436-41.
Guerrini R, Bonanni P, Parmeggiani L, Belmonte A. Adolescent onset of idiopathic photosensitive occipital epilepsy after remission of benign rolandic epilepsy. Epilepsia. 1997;38(7):777-81.
Arsov T, Mullen SA, Rogers S, Phillips AM, Lawrence KM, Damiano JA, et al. Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann Neurol. 2012;72(5):807-15.
Ames FR, Saffer D. The sunflower syndrome. A new look at “self-induced” photosensitive epilepsy. J Neurol Sci. 1983;59(1):1-11.
Baumer FM, Porter BE. Clinical and electrographic features of sunflower syndrome. Epilepsy Res. 2018;142:58-63.
Wang X-L, Bao J-X, Liang-Shi, Tie-Ma, Deng Y-C, Zhao G, et al. Jeavons syndrome in China. Epilepsy Behav. 2014;32:64-71.
Giannakodimos S, Panayiotopoulos CP. Eyelid myoclonia with absences in adults: a clinical and video-EEG study. Epilepsia. 1996;37(1):36-44.
Covanis A. Eyelid myoclonia and absence. Adv Neurol. 2005;95:185-96.
Appleton RE, Panayiotopoulos CP, Acomb BA, Beirne M. Eyelid myoclonia with typical absences: an epilepsy syndrome. J Neurol Neurosurg Psychiatry. 1993;56(12):1312-6.
Smith KM, Youssef PE, Wirrell EC, Nickels KC, Payne ET, Britton JW, et al. Jeavons syndrome: clinical features and response to treatment. Pediatr Neurol. 2018;86:46-51.
Panayiotopoulos CP. Syndromes of idiopathic generalized epilepsies not recognized by the International League Against Epilepsy. Epilepsia. 2005;46(Suppl 9):57-66.
Striano S, Striano P, Nocerino C, Boccella P, Bilo L, Meo R, et al. Eyelid myoclonia with absences: an overlooked epileptic syndrome? Neurophysiol Clin Neurophysiol. 2002;32(5):287-96.
Camfield CS, Camfield PR, Sadler M, Rahey S, Farrell K, Chayasirisobbon S, et al. Paroxysmal eyelid movements: a confusing feature of generalized photosensitive epilepsy. Neurology. 2004;63(1):40-2.
Belcastro V, Striano P. Self-induction seizures in sunflower epilepsy: a video-EEG report. Epileptic Disord. 2014;16(1):93-5.
Striano S, Capovilla G, Sofia V, Romeo A, Rubboli G, Striano P, et al. Eyelid myoclonia with absences (Jeavons syndrome): a well-defined idiopathic generalized epilepsy syndrome or a spectrum of photosensitive conditions? Epilepsia. 2009;50:15-9.
Singhi PD, Bansal D. Self induced photosensitive epilepsy. Indian J Pediatr. 2004;71(7):649-51.
Sadleir LG, Vears D, Regan B, Redshaw N, Bleasel A, Scheffer IE. Family studies of individuals with eyelid myoclonia with absences. Epilepsia. 2012;53(12):2141-8.
Kasteleijn-Nolst Trenité D, Rubboli G, Hirsch E, Martins da Silva A, Seri S, Wilkins A, et al. Methodology of photic stimulation revisited: updated European algorithm for visual stimulation in the EEG laboratory. Epilepsia. 2012;53(1):16-24.
Capovilla G, Striano P, Gambardella A, Beccaria F, Hirsch E, Casellato S, et al. Eyelid fluttering, typical EEG pattern, and impaired intellectual function: a homogeneous epileptic condition among the patients presenting with eyelid myoclonia. Epilepsia. 2009;50(6):1536-41.
Thomas RH, Zhang LM, Carvill GL, Archer JS, Heavin SB, Mandelstam SA, et al. CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures. Neurology. 2015;84(9):951-8.
Vlaskamp DRM, Shaw BJ, Burgess R, Mei D, Montomoli M, Xie H, et al. SYNGAP1 encephalopathy. Neurology. 2019;92(2):e96-107.
Stamberger H, Hammer TB, Gardella E, Vlaskamp DRM, Bertelsen B, Mandelstam S, et al. NEXMIF encephalopathy: an X-linked disorder with male and female phenotypic patterns. Genet Med. 2021;23(2):363-73.
Bureau M, Tassinari CA. Epilepsy with myoclonic absences. Brain Dev. 2005;27(3):178-84.
Genton P, Bureau M. Epilepsy with myoclonic absences. CNS Drugs. 2006;20(11):911-6.
Zanzmera P, Menon RN, Karkare K, Soni H, Jagtap S, Radhakrishnan A. Epilepsy with myoclonic absences: electroclinical characteristics in a distinctive pediatric epilepsy phenotype. Epilepsy Behav. 2016;64:242-7.
Myers KA, Scheffer IE. Myoclonic absence seizures with complex gestural automatisms. Eur J Paediatr Neurol. 2018;22(3):532-5.
Elia M, Guerrini R, Musumeci SA, Bonanni P, Gambardella A, Aguglia U. Myoclonic absence-like seizures and chromosome abnormality syndromes. Epilepsia. 1998;39(6):660-3.
Myers KA, Scheffer IE. Myoclonic absence seizures in Dravet syndrome. Pediatr Neurol. 2017;70:67-9.
Bahi-Buisson N, El Sabbagh S, Soufflet C, Escande F, Boddaert N, Valayannopoulos V, et al. Myoclonic absence epilepsy with photosensitivity and a gain of function mutation in glutamate dehydrogenase. Seizure. 2008;17(7):658-64.
Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512-21.
Specchio N, Curatolo P. Developmental and epileptic encephalopathies: what we do and do not know. Brain. 2021;144(1):32-43.
Doose H. Myoclonic-astatic epilepsy. Epilepsy Res Suppl. 1992;6:163-8.
Kelley SA, Kossoff EH. Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress. Dev Med Child Neurol. 2010;52(11):988-93.
Tang S, Pal DK. Dissecting the genetic basis of myoclonic-astatic epilepsy. Epilepsia. 2012;53(8):1303-13.
Doose H, Gerken H, Leonhardt R, Völzke E, Völz C. Centrencephalic myoclonic-astatic petit mal 1-clinical and genetic investigations. Neuropediatrics. 1970;2(1):59-78.
Neubauer BA, Hahn A, Doose H, Tuxhorn I. Myoclonic-astatic epilepsy of early childhood-definition, course, nosography, and genetics. Adv Neurol. 2005;95:147-55.
Kilaru S, Bergqvist AGC. Current treatment of myoclonic astatic epilepsy: clinical experience at the Children’s Hospital of Philadelphia. Epilepsia. 2007;48(9):1703-7.
Kaminska A, Ickowicz A, Plouin P, Bru M, Dellatolas G, Dulac O. Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis. Epilepsy Res. 1999;36(1):15-29.
Joshi C, Nickels K, Demarest S, Eltze C, Cross JH, Wirrell E. Results of an international Delphi consensus in epilepsy with myoclonic atonic seizures/Doose syndrome. Seizure. 2021;85:12-8.
Oguni H, Tanaka T, Hayashi K, Funatsuka M, Sakauchi M, Shirakawa S, et al. Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood. Neuropediatrics. 2002;33(3):122-32.
Trivisano M, Specchio N, Cappelletti S, Di Ciommo V, Claps D, Specchio LM, et al. Myoclonic astatic epilepsy: an age-dependent epileptic syndrome with favorable seizure outcome but variable cognitive evolution. Epilepsy Res. 2011;97(1-2):133-41.
Caraballo RH, Chamorro N, Darra F, Fortini S, Arroyo H. Epilepsy with myoclonic atonic seizures: an electroclinical study of 69 patients. Pediatr Neurol. 2013;48(5):355-62.
Eschbach K, Moss A, Joshi C, Angione K, Smith G, Dempsey A, et al. Diagnosis switching and outcomes in a cohort of patients with potential epilepsy with myoclonic-atonic seizures. Epilepsy Res. 2018;147:95-101.
Oguni H, Hayashi K, Imai K, Funatsuka M, Sakauchi M, Shirakawa S, et al. Idiopathic myoclonic-astatic epilepsy of early childhood-nosology based on electrophysiologic and long-term follow-up study of patients. Adv Neurol. 2005;95:157-74.
Nabbout R. Absence of mutations in major GEFS+ genes in myoclonic astatic epilepsy. Epilepsy Res. 2003;56(2-3):127-33.
Scheffer I. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain. 1997;120(3):479-90.
Singh R, Scheffer IE, Crossland K, Berkovic SF. Generalized epilepsy with febrile seizures plus: a common childhood-onset genetic epilepsy syndrome. Ann Neurol. 1999;45(1):75-81.
Wallace RH, Scheffer IE, Barnett S, Richards M, Dibbens L, Desai RR, et al. Neuronal sodium-channel α1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet. 2001;68(4):859-65.
Wallace RH, Wang DW, Singh R, Scheffer IE, George AL, Phillips HA, et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel ß1 subunit gene SCN1B. Nat Genet. 1998;19(4):366-70.
Wolff M, Johannesen KM, Hedrich UBS, Masnada S, Rubboli G, Gardella E, et al. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. Brain. 2017;140(5):1316-36.
Schubert J, Siekierska A, Langlois M, May P, Huneau C, Becker F, et al. Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes. Nat Genet. 2014;46(12):1327-32.
Carvill G, McMahon J, Schneider A, Zemel M, Myers C, Saykally J, et al. Mutations in the GABA transporter SLC6A1 cause epilepsy with myoclonic-atonic seizures. Am J Hum Genet. 2015;96(5):808-15.
Routier L, Verny F, Barcia G, Chemaly N, Desguerre I, Colleaux L, et al. Exome sequencing findings in 27 patients with myoclonic-atonic epilepsy: is there a major genetic factor? Clin Genet. 2019;96(3):254-60.
Warren AEL, Harvey AS, Vogrin SJ, Bailey C, Davidson A, Jackson GD, et al. The epileptic network of Lennox-Gastaut syndrome. Neurology. 2019;93(3):e215-26.
Genton P, Guerrini R, Dravet C. The Lennox-Gsataut syndrome. In: Meinardi H, editor. Handbook of clinical neurology: the epilepsies. Amsterdam, the Netherlands: Elsevier; 2000. p. 211-22.
Berg AT, Levy SR, Testa FM. Evolution and course of early life developmental encephalopathic epilepsies: focus on Lennox-Gastaut syndrome. Epilepsia. 2018;59(11):2096-105.
Goldsmith IL, Zupanc ML, Buchhalter JR. Long-term seizure outcome in 74 patients with Lennox-Gastaut syndrome: effects of incorporating MRI head imaging in defining the cryptogenic subgroup. Epilepsia. 2000;41(4):395-9.
Vignoli A, Oggioni G, De Maria G, Peron A, Savini MN, Zambrelli E, et al. Lennox-Gastaut syndrome in adulthood: long-term clinical follow-up of 38 patients and analysis of their recorded seizures. Epilepsy Behav. 2017;77:73-8.
Kerr M, Kluger G, Philip S. Evolution and management of Lennox-Gastaut syndrome through adolescence and into adulthood: are seizures always the primary issue? Epileptic Disord. 2011;13(S1):15-26.
Kim HJ, Kim HD, Lee JS, Heo K, Kim D-S, Kang H-C. Long-term prognosis of patients with Lennox-Gastaut syndrome in recent decades. Epilepsy Res. 2015;110:10-9.
Ferlazzo E, Nikaronova M, Italiano D, Bureau M, Dravet C, Calarese T, et al. Lennox-Gastaut syndrome in adulthood: clinical and EEG features. Epilepsy Res. 2010;89(2-3):271-7.
Ohtsuka Y, Amano R, Mizukawa M, Ohtahara S. Long-term prognosis of the Lennox-Gastaut syndrome. Psychiatry Clin Neurosci. 1990;44(2):257-64.
Hughes JR, Patil VK. Long term electro-clinical changes in the Lennox-Gastaut syndrome before, during, and after the slow spike-wave pattern. Clin Electroencephalogr. 2002;33(1):1-7.
Lee YJ, Kang H-C, Lee JS, Kim SH, Kim D-S, Shim K-W, et al. Resective pediatric epilepsy surgery in Lennox-Gastaut syndrome. Pediatrics. 2010;125(1):e58-66.
Pillay N, Archer JS, Badawy RAB, Flanagan DF, Berkovic SF, Jackson G. Networks underlying paroxysmal fast activity and slow spike and wave in Lennox-Gastaut syndrome. Neurology. 2013;81(7):665-73.
Epi4K Consortium, Epilepsy Phenome/Genome Project, Allen AS, Berkovic SF, Cossette P, Delanty N, et al. De novo mutations in epileptic encephalopathies. Nature. 2013;501(7466):217-21.
Asadi-Pooya AA. Lennox-Gastaut syndrome: a comprehensive review. Neurol Sci. 2018;39(3):403-14.
Fernández IS, Chapman KE, Peters JM, Kothare SV, Nordli DR, Jensen FE, et al. The Tower of Babel: survey on concepts and terminology in electrical status epilepticus in sleep and continuous spikes and waves during sleep in North America. Epilepsia. 2013;54(4):741-50.
Eksioglu Y, Tas E, Takeoka M, Sarco D, Rotemberg A. Clinical presentation and acute treatment of electrical status epilepticus in sleep and sleep potentiated spikes. Philadelphia, PA: Medical Publishing Practice; 2009. p. A434.
Morikawa T, Seino M, Watanabe Y, Watanabe M, Yagi K. Clinical relevance of continuous spike-waves during slow wave sleep. In: Manelis S, Bental E, Loeber J, Dreifuss F, editors. Advances in epileptology. New York, NY: Raven Press; 1989. p. 359-63.
Singhal NS, Sullivan JE. Continuous spike-wave during slow wave sleep and related conditions. ISRN Neurol. 2014;2014:1-6.
Kersbergen KJ, de Vries LS, Leijten FSS, Braun KPJ, Nievelstein RAJ, Groenendaal F, et al. Neonatal thalamic hemorrhage is strongly associated with electrical status epilepticus in slow wave sleep. Epilepsia. 2013;54(4):733-40.
Neville BGR, Boyd SG. Selective epileptic gait disorder. J Neurol Neurosurg Psychiatry. 1995;58(3):371-3.
van den Munckhof B, Arzimanoglou A, Perucca E, van Teeseling HC, Leijten FSS, Braun KPJ, et al. Corticosteroids versus clobazam in epileptic encephalopathy with ESES: a European multicentre randomised controlled clinical trial (RESCUE ESES*). Trials. 2020;21(1):957.
Caraballo R, Pavlidis E, Nikanorova M, Loddenkemper T. Encephalopathy with continuous spike-waves during slow-wave sleep: evolution and prognosis. Epileptic Disord. 2019;21(S1):15-21.
Gardella E, Cantalupo G, Larsson PG, Fontana E, Bernardina BD, Rubboli G, et al. EEG features in encephalopathy related to status epilepticus during slow sleep. Epileptic Disord. 2019;21(S1):22-30.
Loddenkemper T, Fernández IS, Peters JM. Continuous spike and waves during sleep and electrical status epilepticus in sleep. J Clin Neurophysiol. 2011;28(2):154-64.
Tassinari CA, Cantalupo G, Rios-Pohl L, Della GE, Rubboli G. Encephalopathy with status epilepticus during slow sleep: “the Penelope syndrome”. Epilepsia. 2009;50:4-8.
Perez ER, Davidoff V, Desplartd P-A, Deonna T. Mental and behavioural deterioration of children with epilepsy and CSWS: acquired epileptic frontal syndrome. Dev Med Child Neurol. 2008;35(8):661-74.
Tassinari CA, Rubboli G. Cognition and paroxysmal EEG activities: from a single spike to electrical status epilepticus during sleep. Epilepsia. 2006;47(Suppl 2):40-3.
Van Bogaert P. Epileptic encephalopathy with continuous spike-waves during slow-wave sleep including Landau-Kleffner syndrome. Handb Clin Neurol. 2013;111:635-40.
Tsai M-H, Vears DF, Turner SJ, Smith RL, Berkovic SF, Sadleir LG, et al. Clinical genetic study of the epilepsy-aphasia spectrum. Epilepsia. 2013;54(2):280-7.
Turner SJ, Mayes AK, Verhoeven A, Mandelstam SA, Morgan AT, Scheffer IE. GRIN2A: an aptly named gene for speech dysfunction. Neurology. 2015;84(6):586-93.
Hirsch LJ, Gaspard N, van Baalen A, Nabbout R, Demeret S, Loddenkemper T, et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia. 2018;59(4):739-44.
Van Baalen A, Häusler M, Boor R, Rohr A, Sperner J, Kurlemann G, et al. Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia. 2010;51(7):1323-8.
Payne ET, Koh S, Wirrell EC. Extinguishing febrile infection-related epilepsy syndrome: pipe dream or reality? Semin Neurol. 2020;40(2):263-72.
Specchio N, Pietrafusa N. New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome. Dev Med Child Neurol. 2020;62(8):897-905.
van Baalen A, Häusler M, Plecko-Startinig B, Strautmanis J, Vlaho S, Gebhardt B, et al. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES. Neuropediatrics. 2012;43(4):209-16.
Kramer U, Chi C-S, Lin K-L, Specchio N, Sahin M, Olson H, et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome. Epilepsia. 2011;52(11):1956-65.
Farias-Moeller R, Bartolini L, Staso K, Schreiber JM, Carpenter JL. Early ictal and interictal patterns in FIRES: the sparks before the blaze. Epilepsia. 2017;58(8):1340-8.
Lee H-F, Chi C-S. Febrile infection-related epilepsy syndrome (FIRES): therapeutic complications, long-term neurological and neuroimaging follow-up. Seizure. 2018;56:53-9.
Sakuma H, Tanuma N, Kuki I, Takahashi Y, Shiomi M, Hayashi M. Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus. J Neurol Neurosurg Psychiatry. 2015;86(7):820-2.
Clarkson BDS, LaFrance-Corey RG, Kahoud RJ, Farias-Moeller R, Payne ET, Howe CL. Functional deficiency in endogenous interleukin-1 receptor antagonist in patients with febrile infection-related epilepsy syndrome. Ann Neurol. 2019;85(4):526-37.
Kothur K, Bandodkar S, Wienholt L, Chu S, Pope A, Gill D, et al. Etiology is the key determinant of neuroinflammation in epilepsy: elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus. Epilepsia. 2019;60(8):1678-88.
Gastaut H, Poirier F, Payan H, Salamon G, Toga M, Vigouroux MHHE. Syndrome hemiconvulsions, hemiplegia, epilepsy. Epilepsia. 1959;1(1-5):418-47.
Auvin S, Bellavoine V, Merdariu D, Delanoë C, Elmaleh-Bergés M, Gressens P, et al. Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings. Eur J Paediatr Neurol. 2012;16(5):413-21.
Albakaye M, Belaïdi H, Lahjouji F, Errguig L, Kuate C, Maiga Y, et al. Clinical aspects, neuroimaging, and electroencephalography of 35 cases of hemiconvulsion-hemiplegia syndrome. Epilepsy Behav. 2018;80:184-90.
Aicardi J, Amsili J, Chevrie JJ. Acute hemiplegia in infancy and childhood. Dev Med Child Neurol. 2008;11(2):162-73.
van Toorn R, Janse van Rensburg P, Solomons R, Ndondo AP, Schoeman JF. Hemiconvulsion-hemiplegia-epilepsy syndrome in South African children: insights from a retrospective case series. Eur J Paediatr Neurol. 2012;16(2):142-8.
Kim DW, Kim KK, Chu K, Chung CK, Lee SK. Surgical treatment of delayed epilepsy in hemiconvulsion-hemiplegia-epilepsy syndrome. Neurology. 2008;70(22 Part 2):2116-22.
Toldo I, Calderone M, Boniver C, Dravet C, Guerrini R, Laverda AM. Hemiconvulsion-hemiplegia-epilepsy syndrome: early magnetic resonance imaging findings and neuroradiological follow-up. Brain Dev. 2007;29(2):109-11.
Kim DW, Lim BC, Kim KJ, Chae JH, Lee R, Lee SK. Low incidence of SCN1A genetic mutation in patients with hemiconvulsion-hemiplegia-epilepsy syndrome. Epilepsy Res. 2013;106(3):440-5.

Auteurs

Nicola Specchio (N)

Rare and Complex Epilepsy Unit, Department of Neuroscience, Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Full Member of EpiCARE, Rome, Italy.

Elaine C Wirrell (EC)

Divisions of Child and Adolescent Neurology and Epilepsy, Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

Ingrid E Scheffer (IE)

Austin Health and Royal Children's Hospital, Florey Institute, Murdoch Children's Research Institute, University of Melbourne, Melbourne, Victoria, Australia.

Rima Nabbout (R)

Reference Center for Rare Epilepsies, Department of Pediatric Neurology, Necker-Sick Children Hospital, Public Hospital Network of Paris, member of EpiCARE, Imagine Institute, National Institute of Health and Medical Research, Mixed Unit of Research 1163, University of Paris, Paris, France.

Kate Riney (K)

Neurosciences Unit, Queensland Children's Hospital, South Brisbane, Queensland, Australia.
Faculty of Medicine, University of Queensland, South Brisbane, Queensland, Australia.

Pauline Samia (P)

Department of Pediatrics and Child Health, Aga Khan University, Nairobi, Kenya.

Marilisa Guerreiro (M)

Department of Neurology, University of Campinas, Campinas, Brazil.

Sam Gwer (S)

School of Medicine, Kenyatta University, and Afya Research Africa, Nairobi, Kenya.

Sameer M Zuberi (SM)

Paediatric Neurosciences Research Group, Royal Hospital for Children and Institute of Health & Wellbeing, member of EpiCARE, University of Glasgow, Glasgow, UK.

Jo M Wilmshurst (JM)

Department of Paediatric Neurology, Red Cross War Memorial Children's Hospital, Neuroscience Institute, University of Cape Town, Cape Town, South Africa.

Elissa Yozawitz (E)

Isabelle Rapin Division of Child Neurology of the Saul R. Korey Department of Neurology, Montefiore Medical Center, Bronx, New York, USA.

Ronit Pressler (R)

Programme of Developmental Neurosciences, University College London National Institute for Health Research Biomedical Research Centre Great Ormond Street Institute of Child Health, Department of Clinical Neurophysiology, Great Ormond Street Hospital for Children, London, UK.

Edouard Hirsch (E)

Neurology Epilepsy Units "Francis Rohmer", INSERM 1258, FMTS, Strasbourg University, Strasbourg, France.

Sam Wiebe (S)

Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.

Helen J Cross (HJ)

Programme of Developmental Neurosciences, University College London National Institute for Health Research Biomedical Research Centre Great Ormond Street Institute of Child Health, Great Ormond Street Hospital for Children, and Young Epilepsy Lingfield, London, UK.

Emilio Perucca (E)

Department of Neuroscience, Monash University, Melbourne, Victoria, Australia.
Department of Medicine, Austin Health, University of Melbourne, Heidelberg, Victoria, Australia.

Solomon L Moshé (SL)

Isabelle Rapin Division of Child Neurology, Saul R. Korey Department of Neurology, and Departments of Neuroscience and Pediatrics, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA.

Paolo Tinuper (P)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Institute of Neurological Sciences, Scientific Institute for Research and Health Care, Bologna, Italy.

Stéphane Auvin (S)

Robert Debré Hospital, Public Hospital Network of Paris, NeuroDiderot, National Institute of Health and Medical Research, Department Medico-Universitaire Innovation Robert-Debré, Pediatric Neurology, University of Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH